Metastatic Breast Cancer, Triple Negative Breast Cancer Completed Phase 1 / 2 Trials for Tilarginine (DB11815)

Also known as: Metastatic Triple-negative Breast Cancer / Metastatic Triple Negative Breast Cancer / Triple-negative Metastatic Breast Cancer / Triple Negative Metastatic Breast Cancer

IndicationStatusPhase
DBCOND0074793 (Metastatic Breast Cancer, Triple Negative Breast Cancer)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02834403L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer PatientsTreatment